IBB

Play the Biotech Boom With IBB

Biotech bulls continue to charge forward, sending IBB higher. Capitalize on the biotech sector breakout with call spreads in the IBB ETF. More

Despite the bounce in stocks, bonds, credit and currencies were not singing the same tune, and instead continued to warn of deeper woes. More

The strong advance in iShares NASDAQ Biotechnology Index ETF has been volatile. More

Commodities, healthcare stocks, long-term bonds and Russian stocks were four of the biggest investing themes of 2014. More

The S&P 500 and Dow Jones finished at new highs, but a lack of market breadth during this rebound remains a problem. More

Despite the recent stock market correction, iShares Nasdaq Biotechnology (IBB) remains in an uptrend. More

Many portfolios contain major structural flaws that threaten performance, and investors should identify and eliminate these defects. More